Sensex Declines 800 Points, Dragged by Financials and IT Shares After GDP Data
India’s stock market benchmark fell sharply on Thursday as Dalal Street resumed trading after a one-day holiday, weighed down by losses in financials, IT, oil...
Tag : USFDA
Alembic Gets USFDA Approval for Cancer Treatment Drug
Alembic Pharmaceuticals said in a statement it had received approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Dasatinib tablets of 20...
Lupin Gets Generic Drug Approval from USFDA
Drugmaker Lupin said on Wednesday it had received preliminary approval from US health regulators to sell Ivacaftor tablets for cystic fibrosis in the US. In...
Zydus Receives USFDA Approval for Generic Antacid
On Monday, Zydus Lifesciences said that it had received final approval from US health regulators to market its antacid famotidine tablets in the US market....
Second Dose of Covid Booster for Most Vulnerable Could Bring Benefits, WHO Says
As omicron and its sub-variants continue to spread globally, there may be some benefit to delivering a second dose of a coronavirus booster vaccine to...
Cipla Sees 2% Gains on Zero Observations for Indore Facility
Share prices of Cipla gained 2.5 per cent in the early trade on Monday after USFDA issued zero observation for its Indore facility. At the...
Sun Pharma Clarifies On Its Corporate Governance Issue
Sun Pharmaceutical Industries Ltd today made a press release, today, in order to clarify the ongoing corporate governance issue. Sun Pharma explained that the loan...
Wockhardt Ltd Receives USFDA Approval For Cancer Treatment Drug
Wockhardt Ltd. announced that the drugmaker has received approval from the U.S. health regulator, USFDA, for the generic version of Gleevec used for the treatment...
Pharmaceutical Majors Recall Their Products From USA
According to the latest U.S. Food and Drug Administration’s (USFDA) Enforcement Report, Indian pharma major such as Lupin, Sun Pharma and Glenmark has decided to...
US FDA Approves Zydus Cadila’s HIV-1 Treatment Tablets
Zydus Cadila has announced that the US health regulator has given final approval to market generic Abacavir and Lamivudine tablets, which are primarily used for...